campus all updates: the safety and efficacy of daratumumab for the treatment of all
Published 2 years ago • 68 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
7:30
updates from juliet: correlative analyses and clinical characteristics associated with efficacy
-
3:05
updates on the phase i study of ft-4202 for scd
-
1:13
the main treatment goals in lr-mds and how these differ from hr-mds
-
3:12
an analysis of shared treatment decision-making in patients with r/r dlbcl
-
2:25
a final update of enhance: reflecting on the negative read-out of the study
-
1:43
six-year update from cll14: fixed-duration venetoclax obinutuzumab for previously untreated cll
-
0:54
a research update in richter's transformation from ash 2023
-
1:17
exciting novel treatments being developed for mds
-
4:08
ldh test (lactate dehydrogenase test)
-
42:46
cde series 26: updates in advanced hematology
-
26:46
webinar recording | technology advances in hematology testing | sparrc 2021 by srmc | mindray india
-
2:02
recent advances in all treatment
-
1:17
keynote-667: pembrolizumab plus copdac-28 for high-risk chl with slow early response to oepa
-
1:02
the changing standard of care in dlbcl
-
1:58
mrd as a surrogate endpoint for aml therapy
-
3:47
update on the guidelines for the diagnosis, grading & management of icaht following car-t therapy
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
1:26
improving outcomes in sickle cell disease: expanding access and expediting treatment development
-
3:40
master class in transplantation and hematology: highlights
-
4:18
recent advances in the clinical management of myeloma
-
3:02
euplagia-1: phase i trial of glpg5201, a cd19 car-t product, in r/r cll and richter's transformation
-
58:09
the diabetes epidemic: the latest on treatment and prevention